- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Sprint Bioscience AB
Headquarters: Huddinge, Sweden
Website: http://www.sprintbioscience.c...
Year Founded: 2009
Status: Public
Industry Sector: HealthTechnology
CEO: Johan Emilsson, EMBA
Number Of Employees: 38
Enterprise Value: $7,772,554
PE Ratio: -2.35
Exchange/Ticker 1: SSE:SPRINT
Exchange/Ticker 2: N/A
Latest Market Cap: $7,399,118
BioCentury | Aug 17, 2023
Finance
Aug. 16 Quick Takes: CirCode follows Pfizer deal with JJDC-led series A
Plus: At last, approval Ipsen FOP therapy Sohono and updates from Compass Pathways, Day One-Sprint, Seagen, Artiva, Precision-Imugene, Impel
BioCentury | Apr 22, 2017
Finance
Sweden heating up
How private money and retail investors are fueling Stockholm’s biotech IPO boom
BioCentury | Oct 22, 2012
Emerging Company Profile
Sprint: Quick start in cancer
Sweden's Sprint generates cancer metabolism, autophagy leads to out-license
Items per page:
1 - 6 of 6